Cluster SA_G2_AND_M_PHASES is enriched in the following gene classes
| GeneSet DB | Hit Count |
|---|---|
| Pathways - KEGG_BioCarta.gmt GeneSets | 5 |
| Cluster Name | GeneSet Name | GeneSet DB | log(P) | Qvalue | Observed in Background | Observed in Cluster | Expected in Cluster |
|---|---|---|---|---|---|---|---|
| AZAvsCD3-Up in-CD3-activated | SA G2 AND M PHASES | Pathways - KEGG_BioCarta.gmt GeneSets | -2.6 | 0.04076 | 7.0 | 5.0 | 1.59 |
| EntryvsLatency-Dn in-Resting | SA G2 AND M PHASES | Pathways - KEGG_BioCarta.gmt GeneSets | -3.7 | 0.00113 | 7.0 | 4.0 | 0.59 |
| DISUvsCD3-Dn in-DISU-activated | SA G2 AND M PHASES | Pathways - KEGG_BioCarta.gmt GeneSets | -2.8 | 0.02863 | 7.0 | 5.0 | 1.44 |
| SAHAvsCD3-Dn in-SAHA-activated | SA G2 AND M PHASES | Pathways - KEGG_BioCarta.gmt GeneSets | -2.5 | 0.04498 | 7.0 | 5.0 | 1.66 |
| SAHAvsIL7-Dn in-SAHA-activated | SA G2 AND M PHASES | Pathways - KEGG_BioCarta.gmt GeneSets | -2.9 | 0.01262 | 7.0 | 3.0 | 0.5 |
Download list of genes
Gene expression pattern of SA_G2_AND_M_PHASES
Figure: : Temporal expression patterns are displayed according to the selected conditions and comparisons. Only infected conditions are displayed, during latency as gray lines or during activation according to the color code for each drug. For individual genes, select one from the table below.